Ergomar - Drug Details
๐Ÿ“Š Estimates Ergomar Dialyzability By Different_Modalities

Ergomar

Complete Drug Information

Drug Name
Ergomar
Trade Names
Ergomar
Pregnancy Category
AU: C US: Contraindicated
Bioavailability
Intravenous: 100%, Intramuscular: 47%,Oral: <1% (Enhanced by co-administration of caffeine)
Routes of Administration
Oral
Metabolism
Liver
Elimination
2 hours
Excretion
90% Bile duct
Formula
C33H35N5O5
Molar Mass
581.673
Volume of Distribution
C33H35N5O5

๐Ÿคฐ Pregnancy Category Information

Category: AU: C US: Contraindicated

Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible.